Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-18-000047

Director sold 92,337 shares at $26.96 ($2,489,406)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-01-05 Sale : show line 1 in the form −92,337 $26.96 $2,489,406 1,821,268 I
Open-market sales · 92,337 sh · avg $26.96 · $2,489,406
Loading xslF345X03/crisprfm4_jan52018.xml…